[HTML][HTML] Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system
Despite tremendous global efforts since the beginning of the COVID-19 pandemic, still only
a limited number of prophylactic and therapeutic options are available. Although vaccination …
a limited number of prophylactic and therapeutic options are available. Although vaccination …
Efficacy of nafamostat mesylate in the prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a systematic review and meta-analysis of …
K Narumi, T Okada, Y Lin, S Kikuchi - Scientific Reports, 2023 - nature.com
We conducted a systematic review and meta-analysis to evaluate the effect of nafamostat on
the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) …
the prevention of post-endoscopic retrograde cholangiopancreatography (ERCP) …
Nafamostat Mesylate in Combination with the Mouse Amino-Terminal Fragment of Urokinase–Human Serum Albumin Improves the Treatment Outcome of Triple …
Triple-negative breast cancer (TNBC) is highly aggressive and causes a higher proportion of
metastatic cases. However, therapies directed to specific molecular targets have rarely …
metastatic cases. However, therapies directed to specific molecular targets have rarely …
[HTML][HTML] 甲磺酸萘莫司他在凝血功能障碍患者连续肾脏替代治疗中的应用研究
卢自文， 郑祥德 - Advances in Clinical Medicine, 2023 - hanspub.org
凝血功能障碍患者实施体外血液净化时, 应用肝素常规抗凝, 可增加消化道,
肺和颅内出血等风险; 应用枸橼酸体外抗凝, 由于重症患者常合并肝肾功能不全 …
肺和颅内出血等风险; 应用枸橼酸体外抗凝, 由于重症患者常合并肝肾功能不全 …
Inhibition of Listeria Monocytogenes HtrA Protease with Camostat, Gabexate and Nafamostat Mesylates and the Binding Mode of the Inhibitors
S Wessler, K Ponnuraj - The Protein Journal, 2023 - Springer
In many bacteria, the High Temperature requirement A (HtrA) protein functions as a
chaperone and protease. HtrA is an important factor in stress tolerance and plays a …
chaperone and protease. HtrA is an important factor in stress tolerance and plays a …
[引用][C] Исследование in silico производных гуанидинбензойной кислоты как потенциальных препаратов с антиметастатической активностью
ДС Байроченко - 2023 - БГМУ